TNF and rheumatoid arthritis: There are currently 3 anti–tumor necrosis factor α (anti-TNFα) drugs licensed for use in rheumatoid arthritis (RA) in the UK: infliximab and adalimumab, both monoclonal antibodies, and etanercept, a TNFα receptor fusion protein.